Amplyx Pharmaceuticals

Amplyx Pharmaceuticals
Last activity: 06.07.2021
Amplyx was founded on a mission to save lives by developing a new class of antifungal medicine that would overcome the severe limitations of today’s therapeutic options. We are developing first-in-class products for the treatment of life-threatening infections, with a near-term focus on deadly fungal pathogens in vulnerable, immune-compromised patients. Amplyx’s leadership has extensive experience developing drugs to treat infectious diseases, as well as treatments for rare conditions. For more information on Amplyx, please visit our website at
Location: United States, California, San Diego
Employees: 11-50
Total raised: $207.7M

Investors 8

Funding Rounds 5

DateSeriesAmountInvestorsDeal News
20.05.2020Series C$90MSofinnova
02.08.2017Series C$67MNew Enterp...socaltech....
11.11.2015Series B$

Mentions in press and media 23

03.12.2020Amplyx Announces Upcoming Virtual Data Presentations at 62nd... SAN DIEGO, Dec. 3, 2020 /PRNewswire/ -- Amplyx Pharmaceuticals, a clinical-stage biopharmaceutical...prnewswire...
06.11.2020Covid-19 roundup: No­var­tis treat­ment comes up short in Ph...A ma­jor play­er try­ing to adapt an an­ti-in­flam­ma­to­ry for Covid-19 has seen the drug fall
20.05.2020Amplyx closes $53 million Series C extension-arixbiosci...
19.05.2020 Amplyx Pharmaceuticals Adds $53M In Funding San Diego-based Amplyx Pharmaceuticals has raised $53M in a Series C extension funding, bringing its...socaltech....
19.05.2020Amplyx Pharmaceuticals Closes $53M Series C ExtensionAmplyx Pharmaceuticals, a San Diego, CA-based biotech company developing innovative therapies for
19.05.2020Immune Therapeutics Company Amplyx Pharmaceuticals Adds $53M...-connect.or...
17.09.2019Am­gen inks dis­cov­ery deal with Hum­ming­bird; Mer­ck gain...→ Am­gen has en­list­ed Hum­ming­bird Bio­science on a new an­ti­body dis­cov­ery pact, turn­ing
03.08.2017Term Sheet — Thursday, Aug. 3MARKDOWNS AGAIN After we wrote about mutual fund markdowns to Uber’s share price, a few readers
02.08.2017 Amplyx Pharmaceuticals Gets $67M San Diego-based Amplyx Pharmaceuticals, which develops antifungal agents aimed at treating fungal in...socaltech....
02.08.2017Amplyx Pharmaceuticals Inks $67M in Series C SAN DIEGO, CA, Company developing novel antifungal agents for life-threatening fungal infections, ...vcnewsdail...
Show more